ArticleJournal of clinical microbiology2022

Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020).

Cecilia G Carvalhaes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.